` 301281 (Shandong Keyuan Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
301281
vs
S
Shanghai Composite

Over the past 12 months, Shandong Keyuan Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +10% compared to the Shanghai Composite's +27% growth.

Stocks Performance
301281 vs Shanghai Composite

Loading
301281
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301281 vs Shanghai Composite

Performance Gap Between 301281 and SSEC
HIDDEN
Show

Performance By Year
301281 vs Shanghai Composite

Loading
301281
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shandong Keyuan Pharmaceutical Co Ltd vs Peers

Shanghai Composite
301281
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shandong Keyuan Pharmaceutical Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Pharmaceuticals

Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.

Shandong Keyuan Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top